Checkpoint Therapeutics, Inc.

NasdaqCM:CKPT Stock Report

Market Cap: US$178.2m

Checkpoint Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:CKPT Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
19 Dec 24SellUS$3,074,764James OlivieroIndividual822,397US$3.87
18 Dec 24SellUS$1,076,412William GrayIndividual268,432US$4.01
26 Jun 24SellUS$26,858William GrayIndividual13,038US$2.06
26 Jun 24SellUS$50,451James OlivieroIndividual24,610US$2.05
28 Feb 24SellUS$4,212William GrayIndividual2,035US$2.07
28 Feb 24SellUS$12,142James OlivieroIndividual5,894US$2.06
01 Feb 24SellUS$23,919James OlivieroIndividual11,900US$2.01
01 Feb 24SellUS$8,024William GrayIndividual4,115US$1.95

Insider Trading Volume

Insider Buying: CKPT insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of CKPT?
Owner TypeNumber of SharesOwnership Percentage
Institutions3,838,9627.86%
Individual Insiders4,078,1598.35%
Public Companies4,435,5349.08%
Hedge Funds4,573,7469.37%
General Public31,906,09965.3%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 107.6%.

Top Shareholders

Top 25 shareholders own 33.22% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.37%
Armistice Capital LLC
4,573,746US$16.7m82.5%0.37%
9.08%
Fortress Biotech, Inc.
4,435,534US$16.2m3.41%no data
4.7%
James Oliviero
2,294,583US$8.4m18.3%no data
2.81%
The Vanguard Group, Inc.
1,374,306US$5.0m2.79%no data
2.11%
William Gray
1,032,754US$3.8m53.6%no data
0.88%
Geode Capital Management, LLC
427,651US$1.6m41.2%no data
0.43%
BlackRock, Inc.
209,583US$765.0k3.31%no data
0.31%
PVG Asset Management Corp
149,870US$547.0k9.24%2.01%
0.3%
Lindsay Rosenwald
144,812US$528.6k9.56%no data
0.28%
Neil Herskowitz
134,812US$492.1k15.1%no data
0.28%
Barry Salzman
134,812US$492.1k15.1%no data
0.27%
Wealth Enhancement Advisory Services, LLC
130,000US$474.5k160%no data
0.27%
Christian Béchon
129,523US$472.8k13.1%no data
0.26%
Michael Weiss
124,812US$455.6k11.3%no data
0.21%
Morgan Stanley, Investment Banking and Brokerage Investments
103,659US$378.3k873%no data
0.19%
State Street Global Advisors, Inc.
94,424US$344.6k32.2%no data
0.19%
Susquehanna International Group, LLP, Asset Management Arm
92,142US$336.3k50.7%no data
0.18%
Renaissance Technologies LLC
88,790US$324.1k15%no data
0.18%
D. E. Shaw & Co., L.P.
88,422US$322.7k92.4%no data
0.17%
Legacy Wealth Asset Management, LLC
85,000US$310.2k0%0.08%
0.17%
Envestnet Asset Management, Inc.
83,632US$305.3k0.33%no data
0.17%
Amit Sharma
82,051US$299.5k0%no data
0.16%
HB Wealth Management, LLC
78,000US$284.7k0%no data
0.14%
Walleye Capital LLC
65,948US$240.7k0%no data
0.13%
Marshall Wace LLP
62,703US$228.9k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/05 07:51
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Checkpoint Therapeutics, Inc. is covered by 7 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mayank MamtaniB. Riley Securities, Inc.
Justin WalshB. Riley Securities, Inc.
Jonathan AschoffB. Riley Wealth